About Geneplus Technology
Geneplus Technology is a company based in Beijing (China) founded in 2015 by Yi Xin and Yang Ling.. Geneplus Technology has raised $220.24 million across 5 funding rounds from investors including BGI, Huada Gene and Aier Eye Hospital. Geneplus Technology operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Beijing, China
- Founders Yi Xin, Yang Ling
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$220.24 M (USD)
in 5 rounds
-
Latest Funding Round
$115.82 M (USD), Series C
Jul 22, 2021
-
Investors
BGI
& 16 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Geneplus Technology
Geneplus Technology has successfully raised a total of $220.24M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $115.82 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $115.8M
-
First Round
First Round
(26 Aug 2016)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series C - Geneplus Technology | Valuation | CCB International | |
| Nov, 2020 | Amount | Series B - Geneplus Technology | Valuation | Huagai Capital | |
| Jul, 2019 | Amount | Series B - Geneplus Technology | Valuation | CoStone Capital , Huada Gene |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Geneplus Technology
Geneplus Technology has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include BGI, Huada Gene and Aier Eye Hospital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Jinmao Capital is established as a central enterprise financial platform.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Geneplus Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Geneplus Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Geneplus Technology Comparisons
Competitors of Geneplus Technology
Geneplus Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| domain | founded_year | HQ Location |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Geneplus Technology
When was Geneplus Technology founded?
Geneplus Technology was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Geneplus Technology located?
Geneplus Technology is headquartered in Beijing, China.
Who is the current CEO of Geneplus Technology?
Yi Xin is the current CEO of Geneplus Technology. They have also founded this company.
Is Geneplus Technology a funded company?
Geneplus Technology is a funded company, having raised a total of $220.24M across 5 funding rounds to date. The company's 1st funding round was a Series B of $29.06M, raised on Aug 26, 2016.
What does Geneplus Technology do?
Geneplus Technology was established in 2015 in Beijing, China, within the biotechnology sector. Devices and reagents for laboratory applications are produced, including gene sequencers, human gene mutation detection kits, and pathogenic detection kits. CRO services for research purposes are also provided. Operations focus on advancing genomic tools and supporting scientific investigations in the region.
Who are the top competitors of Geneplus Technology?
Geneplus Technology's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Who are Geneplus Technology's investors?
Geneplus Technology has 17 investors. Key investors include BGI, Huada Gene, Aier Eye Hospital, Alibaba Health, and Beijing Rongzhilian Technology.